NIR fluorescence-guided tumor surgery: new strategies for the use of indocyanine green

References

• Nagaya T, Nakamura YA, Choyke PL, Kobayashi H. Fluorescence-guided surgery. Front Oncol. 2017;7:314. doi:10.3389/fonc.2017.0031429312886
   PubMedGoogle Scholar
• Hill TK, Mohs AM. Image-guided tumor surgery: will there be a role for fluorescent nanoparticles? Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016;8:498–511. doi:10.1002/wnan.138126585556
   PubMedGoogle Scholar
• Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66:271–289. doi:10.3322/caac.2134927253694
   PubMed Web of Science ®Google Scholar
• Jones AS, Bin Hanafi Z, Nadapalan V, Roland NJ, Kinsella A, Helliwell TR. Do positive resection margins after ablative surgery for head and neck cancer adversely affect prognosis? A study of 352 patients with recurrent carcinoma following radiotherapy treated by salvage surgery. Br J Cancer. 1996;74:128–132. doi:10.1038/bjc.1996.3278679446
   PubMedGoogle Scholar
• Atallah I, Milet C, Henry M, et al. Near-infrared fluorescence imaging-guided surgery improves recurrence-free survival rate in novel orthotopic animal model of head and neck squamous cell carcinoma. Head Neck. 2016;38 Suppl 1:E246–E255. doi:10.1002/hed.2398025546527
   PubMedGoogle Scholar
• Clayton CE, Marsh KA, Dyson A, et al. Ultrahigh-gradient acceleration of injected eletrons by laser-excited relativistic electron plasma waves. Phys Rev Lett. 1993;70:37–40. doi:10.1103/PhysRevLett.70.403410053252
   PubMedGoogle Scholar
• Layland MK, Sessions DG, Lenox J. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Laryngoscope. 2005;115:629–639. doi:10.1097/01.mlg.0000161338.54515.b115805872
   PubMed Web of Science ®Google Scholar
• Rosenthal EL, Warram JM, Bland KI, Zinn KR. The status of contemporary image-guided modalities in oncologic surgery. Ann Surg. 2015;261:46–55. doi:10.1097/SLA.000000000000075625599326
   PubMedGoogle Scholar
• Van Driel PB, van de Giessen M, Boonstra MC, et al. Characterization and evaluation of the artemis camera for fluorescence-guided cancer surgery. Mol Imaging Biol MIB Off Publ Acad Mol Imaging. 2015;17:413–423. doi:10.1007/s11307-014-0799-z
   PubMed Web of Science ®Google Scholar
• Yokoyama J, Fujimaki M, Ohba S, et al. A feasibility study of NIR fluorescent image-guided surgery in head and neck cancer based on the assessment of optimum surgical time as revealed through dynamic imaging. OncoTargets Ther. 2013;6:325–330. doi:10.2147/OTT.S42006
   PubMed Web of Science ®Google Scholar
• Luo S, Zhang E, Su Y, Cheng T, Shi C. A review of NIR dyes in cancer targeting and imaging. Biomaterials. 2011;32:7127–7138. doi:10.1016/j.biomaterials.2011.06.02421724249
   PubMed Web of Science ®Google Scholar
• Moore GE, Peyton WT. The clinical use of fluorescein in neurosurgery; the localization of brain tumors. J Neurosurg. 1948;5:392–398. doi:10.3171/jns.1948.5.4.039218872412
   PubMed Web of Science ®Google Scholar
• Cho S, Salinas R, Lee J. Indocyanine-green for fluorescence-guided surgery of brain tumors: evidence, techniques, and practical experience. Front Surg. 2019;6:11. doi:10.3389/fsurg.2019.0001130915339
   PubMed Web of Science ®Google Scholar
• Belykh E, Martirosyan NL, Yagmurlu K, et al. intraoperative fluorescence imaging for personalized brain tumor resection: current state and future directions. Front Surg. 2016;17(3):55.
   Google Scholar
• Frangioni JV. New technologies for human cancer imaging. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26:4012–4021. doi:10.1200/JCO.2007.14.3065
   PubMed Web of Science ®Google Scholar
• Schaafsma BE, Mieog JSD, Hutteman M, et al. The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol. 2011;104:323–332. doi:10.1002/jso.2194321495033
   PubMed Web of Science ®Google Scholar
• Frangioni JV. The problem is background, not signal. Mol Imaging. 2009;8:303–304. doi:10.2310/7290.2009.0003320003888
   PubMedGoogle Scholar
• Lee JH, Park G, Hong GH, Choi J, Choi HS. Design considerations for targeted optical contrast agents. Quant Imaging Med Surg. 2012;2:266–273.23289086
   PubMedGoogle Scholar
• Jo D, Hyun H. Structure-inherent targeting of near-infrared fluorophores for image-guided surgery. Chonnam Med J. 2017;53:95–102. doi:10.4068/cmj.2017.53.2.9528584787
   PubMedGoogle Scholar
• Bredell MG. Sentinel lymph node mapping by indocyanin green fluorescence imaging in oropharyngeal cancer - preliminary experience. Head Neck Oncol. 2010;2:31. doi:10.1186/1758-3284-2-3121034503
   PubMedGoogle Scholar
• Van der Vorst JR, Schaafsma BE, Verbeek FPR, et al. Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients. Oral Oncol. 2013;49:15–19. doi:10.1016/j.oraloncology.2012.11.01022939692
   PubMed Web of Science ®Google Scholar
• Atallah I, Milet C, Quatre R, et al. Role of near-infrared fluorescence imaging in the resection of metastatic lymph nodes in an optimized orthotopic animal model of HNSCC. Eur Ann Otorhinolaryngol Head Neck Dis. 2015;132:337–342. doi:10.1016/j.anorl.2015.08.02226409829
   PubMedGoogle Scholar
• Digonnet A, van Kerckhove S, Moreau M, et al. Near infrared fluorescent imaging after intravenous injection of indocyanine green during neck dissection in patients with head and neck cancer: a feasibility study. Head Neck. 2016;38 Suppl 1:E1833–E1837. doi:10.1002/hed.2433126699164
   PubMedGoogle Scholar
• Matsui A, Tanaka E, Choi HS, et al. Real-time intra-operative near-infrared fluorescence identification of the extrahepatic bile ducts using clinically available contrast agents. Surgery. 2010;148:87–95. doi:10.1016/j.surg.2009.12.00420117813
   PubMed Web of Science ®Google Scholar
• Zelken JA, Tufaro AP. Current trends and emerging future of indocyanine green usage in surgery and oncology: an update. Ann Surg Oncol. 2015;22 Suppl 3:S1271–S1283. doi:10.1245/s10434-015-4743-526193966
   PubMedGoogle Scholar
• Moody ED, Viskari PJ, Colyer CL. Non-covalent labeling of human serum albumin with indocyanine green: a study by capillary electrophoresis with diode laser-induced fluorescence detection. J Chromatogr B Biomed Sci App. 1999;729:55–64. doi:10.1016/S0378-4347(99)00121-8
   PubMed Web of Science ®Google Scholar
• Ogawa M, Kosaka N, Choyke PL, Kobayashi H. In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green. Cancer Res. 2009;69:1268–1272. doi:10.1158/0008-5472.CAN-08-366019176373
   PubMed Web of Science ®Google Scholar
• Altinoğlu EI, Russin TJ, Kaiser JM, et al. Near-infrared emitting fluorophore-doped calcium phosphate nanoparticles for in vivo imaging of human breast cancer. ACS Nano. 2008;2:2075–2084. doi:10.1021/nn800448r19206454
   PubMed Web of Science ®Google Scholar
• Schulze T, Bembenek A, Schlag PM. Sentinel lymph node biopsy progress in surgical treatment of cancer. Langenbecks Arch Surg. 2004;389:532–550. doi:10.1007/s00423-004-0484-915197548
   PubMedGoogle Scholar
• Owens EA, Henary M, El Fakhri G, Choi HS. Tissue-specific near-infrared fluorescence imaging. Acc Chem Res. 2016;49:1731–1740. doi:10.1021/acs.accounts.6b0023927564418
   PubMed Web of Science ®Google Scholar
• Choi HS, Frangioni JV. Nanoparticles for biomedical imaging: fundamentals of clinical translation. Mol Imaging. 2010;9:291–310. doi:10.2310/7290.2010.0003121084027
   PubMed Web of Science ®Google Scholar
• Choi HS, Liu W, Liu F, et al. Design considerations for tumour-targeted nanoparticles. Nat Nanotechnol. 2010;5:42–47. doi:10.1038/nnano.2009.31419893516
   PubMed Web of Science ®Google Scholar
• Hellebust A, Richards-Kortum R. Advances in molecular imaging: targeted optical contrast agents for cancer diagnostics. Nanomed. 2012;7:429–445. doi:10.2217/nnm.12.12
   PubMed Web of Science ®Google Scholar
• Owens EA, Lee S, Choi J, Henary M, Choi HS. NIR fluorescent small molecules for intraoperative imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015;7:828–838. doi:10.1002/wnan.133725645081
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Ogawa M, Alford R, Choyke PL, Urano Y. New strategies for fluorescent probe design in medical diagnostic imaging. Chem Rev. 2010;110:2620–2640. doi:10.1021/cr900263j20000749
   PubMed Web of Science ®Google Scholar
• Faraji AH, Wipf P. Nanoparticles in cellular drug delivery. Bioorg Med Chem. 2009;17:2950–2962. doi:10.1016/j.bmc.2009.02.04319299149
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res. 2003;42:463–478. doi:10.1016/S0163-7827(03)00033-X14559067
   PubMed Web of Science ®Google Scholar
• Saxena V, Sadoqi M, Shao J. Degradation kinetics of indocyanine green in aqueous solution. J Pharm Sci. 2003;92:2090–2097. doi:10.1002/jps.1047014502548
   PubMed Web of Science ®Google Scholar
• Mordon S, Devoisselle JM, Soulie-Begu S, Desmettre T. Indocyanine green: physicochemical factors affecting its fluorescence in vivo. Microvasc Res. 1998;55:146–152. doi:10.1006/mvre.1997.20559521889
   PubMed Web of Science ®Google Scholar
• Wang H, Li X, Tse BW-C, et al. Indocyanine green-incorporating nanoparticles for cancer theranostics. Theranostics. 2018;8:1227–1242. doi:10.7150/thno.2287229507616
   PubMed Web of Science ®Google Scholar
• Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2011;63:136–151. doi:10.1016/j.addr.2010.04.00920441782
   PubMed Web of Science ®Google Scholar
• Bertrand N, Wu J, Xu X, Kamaly N, Farokhzad OC. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev. 2014;66:2–25. doi:10.1016/j.addr.2013.11.00924270007
   PubMed Web of Science ®Google Scholar
• Millard M, Yakavets I, Zorin V, Kulmukhamedova A, Marchal S, Bezdetnaya L. Drug delivery to solid tumors: the predictive value of the multicellular tumor spheroid model for nanomedicine screening. Int J Nanomedicine. 2017;12:7993–8007. doi:10.2147/IJN.S14692729184400
   PubMed Web of Science ®Google Scholar
• Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003;3:401–410. doi:10.1038/nrc109312778130
   PubMed Web of Science ®Google Scholar
• Hobbs SK, Monsky WL, Yuan F, et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A. 1998;95:4607–4612. doi:10.1073/pnas.95.8.46079539785
   PubMed Web of Science ®Google Scholar
• Hashizume H, Baluk P, Morikawa S, et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol. 2000;156:1363–1380. doi:10.1016/S0002-9440(10)64698-610751361
   PubMed Web of Science ®Google Scholar
• Iyer AK, Khaled G, Fang J, Maeda H. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today. 2006;11:812–818. doi:10.1016/j.drudis.2006.07.00516935749
   PubMed Web of Science ®Google Scholar
• Jang SH, Wientjes MG, Lu D, Au JLS. Drug delivery and transport to solid tumors. Pharm Res. 2003;20:1337–1350. doi:10.1023/A:102578550597714567626
   PubMed Web of Science ®Google Scholar
• Lee C-H, Cheng S-H, Wang Y-J, et al. Near-infrared mesoporous silica nanoparticles for optical imaging: characterization and in vivo biodistribution. Adv Funct Mater. 2009;19: 215–222. doi:10.1002/adfm.200800753
   Web of Science ®Google Scholar
• Trewyn BG, Giri S, Slowing II, Lin VS-Y. Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems. Chem Commun Camb Engl. 2007;3236–3245. doi:10.1039/b701744h
   PubMed Web of Science ®Google Scholar
• Souris JS, Lee C-H, Cheng S-H, et al. Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. Biomaterials. 2010;31:5564–5574. doi:10.1016/j.biomaterials.2010.01.04220417962
   PubMed Web of Science ®Google Scholar
• Chen J, Liu C, Zeng G, et al. Indocyanine green loaded reduced graphene oxide for in vivo photoacoustic/fluorescence dual-modality tumor imaging. Nanoscale Res Lett. 2016;11:85. doi:10.1186/s11671-016-1288-x26868422
   PubMed Web of Science ®Google Scholar
• Ashokan A, Gowd GS, Somasundaram VH, et al. Multifunctional calcium phosphate nano-contrast agent for combined nuclear, magnetic and near-infrared in vivo imaging. Biomaterials. 2013;34:7143–7157. doi:10.1016/j.biomaterials.2013.05.07723791501
   PubMedGoogle Scholar
• Song S, Shen H, Yang T, et al. Indocyanine green loaded magnetic carbon nanoparticles for near infrared fluorescence/magnetic resonance dual-modal imaging and photothermal therapy of tumor. ACS Appl Mater Interfaces. 2017;9:9484–9495. doi:10.1021/acsami.7b0049028256824
   PubMedGoogle Scholar
• Zhao P, Zheng M, Yue C, et al. Improving drug accumulation and photothermal efficacy in tumor depending on size of ICG loaded lipid-polymer nanoparticles. Biomaterials. 2014;35:6037–6046. doi:10.1016/j.biomaterials.2014.01.02624776486
   PubMed Web of Science ®Google Scholar
• Wu L, Fang S, Shi S, Deng J, Liu B, Cai L. Hybrid polypeptide micelles loading indocyanine green for tumor imaging and photothermal effect study. Biomacromolecules. 2013;14:3027–3033. doi:10.1021/bm400426f23941524
   PubMed Web of Science ®Google Scholar
• Kim TH, Chen Y, Mount CW, Gombotz WR, Li X, Pun SH. Evaluation of temperature-sensitive, indocyanine green-encapsulating micelles for noninvasive near-infrared tumor imaging. Pharm Res. 2010;27:1900–1913. doi:10.1007/s11095-010-0190-y20568000
   PubMed Web of Science ®Google Scholar
• Mok H, Jeong H, Kim S-J, Chung BH. Indocyanine green encapsulated nanogels for hyaluronidase activatable and selective near infrared imaging of tumors and lymph nodes. Chem Commun Camb Engl. 2012;48:8628–8630. doi:10.1039/c2cc33555g
   PubMed Web of Science ®Google Scholar
• Hill TK, Abdulahad A, Kelkar SS, et al. Indocyanine green-loaded nanoparticles for image-guided tumor surgery. Bioconjug Chem. 2015;26:294–303. doi:10.1021/bc500567925565445
   PubMed Web of Science ®Google Scholar
• Luk BT, Fang RH, Zhang L. Lipid- and polymer-based nanostructures for cancer theranostics. Theranostics. 2012;2:1117–1126. doi:10.7150/thno.438123382770
   PubMedGoogle Scholar
• Suganami A, Iwadate Y, Shibata S, et al. Liposomally formulated phospholipid-conjugated indocyanine green for intra-operative brain tumor detection and resection. Int J Pharm. 2015;496:401–406. doi:10.1016/j.ijpharm.2015.10.00126453781
   PubMedGoogle Scholar
• Mérian J, Boisgard R, Bayle P-A, Bardet M, Tavitian B, Texier I. Comparative biodistribution in mice of cyanine dyes loaded in lipid nanoparticles. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Pharm Verfahrenstechnik EV. 2015;93:1–10. doi:10.1016/j.ejpb.2015.03.019
   Google Scholar
• Chopra A. Folic acid-indocyanine green-poly(d,l-lactide-coglycolide)-lipid nanoparticles In: Molecular Imaging and Contrast Agent Database (MICAD) [internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004.
   Google Scholar
• Xin Y, Liu T, Yang C. Development of PLGA-lipid nanoparticles with covalently conjugated indocyanine green as a versatile nanoplatform for tumor-targeted imaging and drug delivery. Int J Nanomedicine. 2016;11:5807–5821. doi:10.2147/IJN.S11999927853366
   PubMed Web of Science ®Google Scholar
• Zheng C, Zheng M, Gong P, et al. Indocyanine green-loaded biodegradable tumor targeting nanoprobes for in vitro and in vivo imaging. Biomaterials. 2012;33:5603–5609. doi:10.1016/j.biomaterials.2012.04.04422575835
   PubMed Web of Science ®Google Scholar
• Zheng X, Xing D, Zhou F, Wu B, Chen WR. Indocyanine green-containing nanostructure as near infrared dual-functional targeting probes for optical imaging and photothermal therapy. Mol Pharm. 2011;8:447–456. doi:10.1021/mp200125j21197955
   PubMed Web of Science ®Google Scholar
• Wu H, Wang H, Liao H, et al. Multifunctional nanostructures for tumor-targeted molecular imaging and photodynamic therapy. Adv Healthc Mater. 2016;5:311–318. doi:10.1002/adhm.20150066826626703
   PubMedGoogle Scholar
• Yan L, Qiu L. Indocyanine green targeted micelles with improved stability for near-infrared image-guided photothermal tumor therapy. Nanomed. 2015;10:361–373. doi:10.2217/nnm.14.118
   PubMed Web of Science ®Google Scholar
• Rodriguez VB, Henry SM, Hoffman AS, Stayton PS, Li X, Pun SH. Encapsulation and stabilization of indocyanine green within poly(styrene-alt-maleic anhydride) block-poly(styrene) micelles for near-infrared imaging. J Biomed Opt. 2008;13:14025. doi:10.1117/1.2834296
   Web of Science ®Google Scholar
• Uthaman S, Bom J, Kim HS, et al. Tumor homing indocyanine green encapsulated micelles for near infrared and photoacoustic imaging of tumors. J Biomed Mater Res B Appl Biomater. 2016;104:825–834. doi:10.1002/jbm.b.3360726743660
   PubMedGoogle Scholar
• Qi B, Crawford AJ, Wojtynek NE, et al. Indocyanine green loaded hyaluronan-derived nanoparticles for fluorescence-enhanced surgical imaging of pancreatic cancer. Nanomed Nanotechnol Biol Med. 2018;14:769–780. doi:10.1016/j.nano.2017.12.015
   PubMed Web of Science ®Google Scholar
• Dosio F, Arpicco S, Stella B, Fattal E. Hyaluronic acid for anticancer drug and nucleic acid delivery. Adv Drug Deliv Rev. 2016;97:204–236. doi:10.1016/j.addr.2015.11.01126592477
   PubMed Web of Science ®Google Scholar
• Bahmani B, Guerrero Y, Bacon D, Kundra V, Vullev VI, Anvari B. Functionalized polymeric nanoparticles loaded with indocyanine green as theranostic materials for targeted molecular near infrared fluorescence imaging and photothermal destruction of ovarian cancer cells. Lasers Surg Med. 2014;46:582–592. doi:10.1002/lsm.v46.724961210
   PubMedGoogle Scholar
• Mac JT, Nuñez V, Burns JM, Guerrero YA, Vullev VI, Anvari B. Erythrocyte-derived nano-probes functionalized with antibodies for targeted near infrared fluorescence imaging of cancer cells. Biomed Opt Express. 2016;7:1311–1322. doi:10.1364/BOE.7.00131127446657
   PubMedGoogle Scholar
• Yamaguchi H, Tsuchimochi M, Hayama K, Kawase T, Tsubokawa N. Dual-labeled near-infrared/(99m)Tc imaging probes using PAMAM-coated silica nanoparticles for the imaging of HER2-expressing cancer cells. Int J Mol Sci. 2016;17(7):E1086. doi:10.3390/ijms17071086.
   PubMed Web of Science ®Google Scholar
• Barthélémy P, Leblanc J, Goldbarg V, Wendling F, Kurtz J-E. Pertuzumab: development beyond breast cancer. Anticancer Res. 2014;34:1483–1491.24692675
   PubMed Web of Science ®Google Scholar
• Steffensen KD, Waldstrøm M, Andersen RF, et al. Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors. Int J Oncol. 2008;33:195–204.18575766
   PubMed Web of Science ®Google Scholar
• Chen W, Ayala-Orozco C, Biswal NC, et al. Targeting pancreatic cancer with magneto-fluorescent theranostic gold nanoshells. Nanomed. 2014;9:1209–1222. doi:10.2217/nnm.13.84
   PubMed Web of Science ®Google Scholar
• Kolitz-Domb M, Grinberg I, Corem-Salkmon E, Margel S. Engineering of near infrared fluorescent proteinoid-poly(L-lactic acid) particles for in vivo colon cancer detection. J Nanobiotechnology. 2014;12:30. doi:10.1186/s12951-014-0030-z25113279
   PubMed Web of Science ®Google Scholar
• Patel RH, Wadajkar AS, Patel NL, Kavuri VC, Nguyen KT, Liu H. Multifunctionality of indocyanine green-loaded biodegradable nanoparticles for enhanced optical imaging and hyperthermia intervention of cancer. J Biomed Opt. 2012;17:46003. doi:10.1117/1.JBO.17.4.046003
   Web of Science ®Google Scholar
• Ding J, Feng M, Wang F, Wang H, Guan W. Targeting effect of PEGylated liposomes modified with the Arg-Gly-Asp sequence on gastric cancer. Oncol Rep. 2015;34:1825–1834. doi:10.3892/or.2015.414226238930
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhao P, Luo Z, et al. Cancer cell membrane-biomimetic nanoparticles for homologous-targeting dual-modal imaging and photothermal therapy. ACS Nano. 2016;10(11):10049–10057. doi:10.1021/acsnano.6b0469527934074
   PubMed Web of Science ®Google Scholar
• Kovalska VB, Volkova KD, Losytskyy MY, Tolmachev OI, Balanda AO, Yarmoluk SM. 6,6ʹ-Disubstituted benzothiazole trimethine cyanines–new fluorescent dyes for DNA detection. Spectrochim Acta A Mol Biomol Spectrosc. 2006;65:271–277. doi:10.1016/j.saa.2005.10.04216497542
   PubMedGoogle Scholar
• Yarmoluk SM, Kovalska VB, Lukashov SS, Slominskii YL. Interaction of cyanine dyes with nucleic acids. XII.beta-substituted carbocyanines as possible fluorescent probes for nucleic acids detection. Bioorg Med Chem Lett. 1999;9:1677–1678. doi:10.1016/S0960-894X(99)00253-X10397499
   PubMed Web of Science ®Google Scholar
• Nakajima T, Mitsunaga M, Bander NH, Heston WD, Choyke PL, Kobayashi H. Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugate. Bioconjug Chem. 2011;22:1700–1705. doi:10.1021/bc200271521740058
   PubMed Web of Science ®Google Scholar
• Sano K, Nakajima T, Miyazaki K, et al. Short PEG-linkers improve the performance of targeted, activatable monoclonal antibody-indocyanine green optical imaging probes. Bioconjug Chem. 2013;24:811–816. doi:10.1021/bc400050k23600922
   PubMedGoogle Scholar
• Villaraza AJL, Milenic DE, Brechbiel MW. Improved speciation characteristics of PEGylated indocyanine green-labeled Panitumumab: revisiting the solution and spectroscopic properties of a near-infrared emitting anti-HER1 antibody for optical imaging of cancer. Bioconjug Chem. 2010;21:2305–2312. doi:10.1021/bc100336b21073171
   PubMedGoogle Scholar
• Zhou Y, Kim Y-S, Milenic DE, Baidoo KE, Brechbiel MW. In vitro and in vivo analysis of indocyanine green-labeled panitumumab for optical imaging-a cautionary tale. Bioconjug Chem. 2014;25:1801–1810. doi:10.1021/bc500312w25243604
   PubMedGoogle Scholar
• Zalipsky S. Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates. Bioconjug Chem. 1995;6:150–165. doi:10.1021/bc00032a0027599259
   PubMed Web of Science ®Google Scholar
• Johnson AJ, Karpatkin MH, Newman J. [Clinical investigation of intermediate- and high-purity antihaemophilic factor (factor VIII) concentrates]. Br J Haematol. 1971;21:21–41. doi:10.1111/j.1365-2141.1971.tb03414.x5314809
   PubMed Web of Science ®Google Scholar
• Mujumdar RB, Ernst LA, Mujumdar SR, Waggoner AS. Cyanine dye labeling reagents containing isothiocyanate groups. Cytometry. 1989;10:11–19. doi:10.1002/(ISSN)1097-03202917470
   PubMedGoogle Scholar
• Sano K, Ohashi M, Kanazaki K, et al. In vivo photoacoustic imaging of cancer using indocyanine green-labeled monoclonal antibody targeting the epidermal growth factor receptor. Biochem Biophys Res Commun. 2015;464:820–825. doi:10.1016/j.bbrc.2015.06.15726168727
   PubMedGoogle Scholar
• Zhang C, Zhang Y, Hong K, Zhu S, Wan J. Photoacoustic and fluorescence imaging of cutaneous squamous cell carcinoma in living subjects using a probe targeting integrin αvβ6. Sci Rep. 2017;7:42442. doi:10.1038/srep4244228181579
   PubMedGoogle Scholar
• Janes SM, Watt FM. Switch from alphavbeta5 to alphavbeta6 integrin expression protects squamous cell carcinomas from anoikis. J Cell Biol. 2004;166:419–431. doi:10.1083/jcb.20031207415289499
   PubMedGoogle Scholar
• Van Aarsen LAK, Leone DR, Ho S, et al. Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism. Cancer Res. 2008;68:561–570. doi:10.1158/0008-5472.CAN-07-230718199553
   PubMed Web of Science ®Google Scholar
• Sano K, Nakajima T, Ali T, et al. Activatable fluorescent cys-diabody conjugated with indocyanine green derivative: consideration of fluorescent catabolite kinetics on molecular imaging. J Biomed Opt. 2013;18:101304. doi:10.1117/1.JBO.18.10.10130423752742
   PubMedGoogle Scholar
• Baik FM, Hansen S, Knoblaugh SE, et al. fluorescence identification of head and neck squamous cell carcinoma and high-risk oral dysplasia with BLZ-100, a chlorotoxin-indocyanine green conjugate. JAMA Otolaryngol– Head Neck Surg. 2016;142:330–338. doi:10.1001/jamaoto.2015.361726892902
   PubMedGoogle Scholar
• Soroceanu L, Gillespie Y, Khazaeli MB, Sontheimer H. Use of chlorotoxin for targeting of primary brain tumors. Cancer Res. 1998;58:4871–4879.9809993
   PubMed Web of Science ®Google Scholar
• Veiseh M, Gabikian P, Bahrami S-B, et al. Tumor paint: a chlorotoxin: cy5.5bioconjugate for intraoperative visualization of cancer foci. Cancer Res. 2007;67:6882–6888. doi:10.1158/0008-5472.CAN-06-394817638899
   PubMed Web of Science ®Google Scholar
• Stroud MR, Hansen SJ, Olson JM. In vivo bio-imaging using chlorotoxin-based conjugates. Curr Pharm Des. 2011;17:4362–4371. doi:10.2174/13816121179899937522204434
   PubMed Web of Science ®Google Scholar
• Kesavan K, Ratliff J, Johnson EW, et al. Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects. J Biol Chem. 2010;285:4366–4374. doi:10.1074/jbc.M109.06609220018898
   PubMed Web of Science ®Google Scholar
• Deshane J, Garner CC, Sontheimer H. Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J Biol Chem. 2003;278:4135–4144. doi:10.1074/jbc.M20566220012454020
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhou L, Zhang J, et al. Green and facile synthesis of a theranostic nanoprobe with intrinsic biosafety and targeting abilities. Nanoscale. 2016;8:16204–16211. doi:10.1039/C6NR01845A27528256
   PubMedGoogle Scholar
• Belykh E, Martirosyan NL, Yagmurlu K, et al. Intraoperative fluorescence imaging for personalized brain tumor resection: current state and future directions. Front Surg. 2016;3:55. doi:10.3389/fsurg.2016.0005527800481
   PubMed Web of Science ®Google Scholar
• Antaris AL, Chen H, Cheng K, et al. A small-molecule dye for NIR-II imaging. Nat Mater. 2016;15:235–242. doi:10.1038/nmat447626595119
   PubMed Web of Science ®Google Scholar
• Bhavane R, Starosolski Z, Stupin I, Ghaghada KB, Annapragada A. NIR-II fluorescence imaging using indocyanine green nanoparticles. Sci Rep. 2018;8:14455. doi:10.1038/s41598-018-32754-y30262808
   PubMedGoogle Scholar
• Zeh R, Sheikh S, Xia L, et al. The second window ICG technique demonstrates a broad plateau period for near infrared fluorescence tumor contrast in glioblastoma. PLoS One. 2017;12:e0182034. doi:10.1371/journal.pone.018203428738091
   PubMed Web of Science ®Google Scholar